About
Diagnostics
Areas of Focus
Categories
Diagnostics
Clinical Trials (35)
View allTotal Trials
35
As Lead Sponsor
14
As Collaborator
21
Total Enrollment
7,031
By Phase
PHASE1: 3PHASE2: 7PHASE4: 2NA: 12PHASE3: 1PHASE2/PHASE3: 2EARLY_PHASE1: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 16RECRUITING: 6WITHDRAWN: 4TERMINATED: 3NOT_YET_RECRUITING: 2UNKNOWN: 2ACTIVE_NOT_RECRUITING: 1APPROVED_FOR_MARKETING: 1
Clinical Trials Pipeline34 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT07032714Collaborator
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
PHASE1Not yet recruiting
25 participants
Started: Dec 16, 2025 · Completed: Jul 1, 2028
NCT06649695Collaborator
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
PHASE2Recruiting
30 participants
Started: Jul 2, 2025 · Completed: Sep 30, 2028
NCT06816992Collaborator
ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLC
PHASE1Recruiting
76 participants
Started: Feb 27, 2025 · Completed: May 31, 2027
NCT06449235Collaborator
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
PHASE4Not yet recruiting
938 participants
Started: Sep 30, 2024 · Completed: Jun 30, 2025
NCT06581562Lead Sponsor
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
PHASE1Recruiting
30 participants
Started: May 15, 2024 · Completed: Dec 31, 2028